EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients.
Select your location
Local sites
Life Sciences
Our Global Life Sciences sector can help you navigate forward and achieve sustainable success in the new health-outcomes-driven ecosystem.
Aging populations and chronic disease are putting pressure on health resources around the world just as scientific progress, augmented intelligence and digital data are transforming the traditional health care models. This is causing a power shift with new entrants (often not driven by profit) disrupting the incumbents.
Staying competitive and providing the personalized experience that patients demand require life sciences organizations to find new ways of working. Partnering with others to share data, medicine and resources while anticipating trends and regulatory changes will help ensure sustainability in the increasingly evidence-based, outcomes-focused sector.
We help companies across the biotechnology, pharmaceutical and medical technology fields harness this disruption by forming the right alliances, better allocating resources and building trust with customers.
Our Latest thinking
Life sciences dealmaking in a time of change
Life sciences companies are returning to dealmaking amid cost and revenue pressures – how will they find the right deals to secure value? Learn more.
08 Jan 2024
Subin Baral
The EY Global Voices in Health Care Study finds health systems must embrace sustainable care delivery models to address workforce challenges. Learn more.
16 Oct 2023
Aloha McBride
Supply chain visibility strategic priority for pharma
With digitally driven end-to-end supply chain visibility, pharma companies will be better prepared for the next major supply chain disruption. Learn more.
04 Oct 2023
Derron Stark
Case study: Takeda’s finance transformation with EY teams
In this case study, learn how leading pharmaceutical company Takeda is creating value for patients through finance innovation and process excellence.
14 Aug 2023
Frederik Schmachtenberg
Innovation can utilize data for value-based care
Organizations have the tools to deliver a better personalized health experience, but the ecosystem needs to collaborate to build this future. Learn more.
20 Mar 2023
Pamela Spence
Life sciences businesses transform tax and finance
Life sciences organizations operate in a complex industry – one that looks set to become more challenging, including from a tax perspective. Learn more.
07 Mar 2023
EY Global
Why life sciences tax departments need to act now on sustainability
Life sciences organizations should consider tax liabilities and compliance obligations resulting from myriad new sustainability taxes. Learn more.
11 Jan 2023
Rick Fonte
How do you build future supply chains to best serve patient needs?
In the wake of global disruptions, EY research aims to map out the future for supply chain transformation in the pharmaceutical industry. Read more.
18 Jul 2022
Derron Stark
Takeda’s journey through digitalization
Find out how Takeda Business Solutions (TBS) fast-tracked its digitalization evolution.
01 Jul 2022
Helmut Rattenberger
How you can create value in an intelligent health ecosystem
The intelligent health ecosystem will provide smarter insights and personalized health care experiences to patients, anytime and anywhere.
26 May 2022
Pamela Spence
How ecosystem participation drives more value for life sciences deals
Biopharmas need to embrace strategic partnerships that share risk and reward to achieve their growth ambitions. Learn more.
10 Jan 2022
Subin Baral
How the future of health care is becoming a reality
Human-centric care will soon become a reality, driven by data and technology.
22 Jun 2021
Pamela Spence
Five trends redefining the health sciences and wellness operating model
As demand from consumers accelerates the adoption of new technologies, we explore how companies can provide a more convenient health experience.
19 May 2021
Pamela Spence
How do you create the care models of tomorrow that are barely imaginable today?
Smart health is about putting the patient at the heart of health services design, and reimagining models of care to realize personalized health at scale.
03 Dec 2020
Aloha McBride
Five trends shaping health care’s data-driven future
Health care can become more resilient, agile and innovative by shifting to digitally enabled business models with data at the core.
03 Dec 2020
Aloha McBride
How you know a hospital is smart
Hyper-connected, intelligent and human-centered, a smart hospital is future proofed for decades to come.
03 Dec 2020
Aloha McBride
Why focusing on what matters to consumers and staff matters most
Good consumer experiences flow through to better workforce experiences and vice versa. Both are good for business.
03 Dec 2020
Aloha McBride
How an ‘accidental entrepreneur’ is on a mission to change capitalism
Biocon’s Dr. Kiran Mazumdar-Shaw shares how she overcame challenges to turn a US$500 investment into one of Asia’s leading biotech companies.
19 Oct 2020
EY Global
How biopharmas can create long-term growth focusing on sustainability
In health care, there is a growing need to embed the perspectives of diverse stakeholders in the sustainability agenda.
16 Oct 2020
Pamela Spence
How life sciences companies reassess their supply chains due to COVID-19
The pandemic has shown the strengths and the weaknesses of life sciences supply chains. Now companies must adapt to build future resilience.
18 Sep 2020
EY Global
How EY can Help
-
The EY Smart Reviewer can help your business accelerate and optimize the review and approval process for marketing and promotional materials. Find out how.
Read more -
Our Biopharma Launch Edge team can help your business achieve successful launches. Find out how.
Read more -
The EY Health Outcomes Platform aligns all stakeholders by providing a practical solution to operate value-based contracts at scale. Find out how.
Read more
Related Documents
Life Sciences Consulting
